Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex

scientific article published on 01 November 1989

Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/CLPT.1989.176
P698PubMed publication ID2582706

P2093author name stringS Broder
R Yarchoan
S S Good
M R Blum
C E Myers
P de Miranda
R V Thomas
P433issue5
P921main subjectAIDS-related complexQ4651855
zidovudineQ198504
pharmacokineticsQ323936
P304page(s)494-500
P577publication date1989-11-01
P1433published inClinical Pharmacology & TherapeuticsQ1101529
P1476titleAlteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex
P478volume46

Reverse relations

cites work (P2860)
Q46577857A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention
Q37302739Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients
Q46691027Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine
Q41292984Clinical pharmacokinetics of zidovudine. An update
Q44129880Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity.
Q40487397Clinical pharmacology of zidovudine and other 2?,3?-dideoxynucleoside analogues
Q40886850Comparative pharmacokinetics of antiviral nucleoside analogues
Q44477319Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration
Q68207621Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans
Q35072074Drug interactions between antiretroviral drugs and comedicated agents
Q36558235Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers
Q44663198Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis
Q72281592Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal
Q35372195Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors
Q36646145Hematologic Effects of AIDS Therapies
Q41537511Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family
Q36757870Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients
Q73850558Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system
Q35124869Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complex
Q41619438Liver slices as a model in drug metabolism.
Q43738146Pharmacokinetic Evaluation of Drug Interactions with Zidovudine. I: Probenecid and Zidovudine in Monkeys
Q40720380Pharmacokinetic drug interactions with antimicrobial agents
Q45880071Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys
Q35138941Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients
Q35120894Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
Q71117298Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole
Q38511971Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus
Q39545308Probenecid interferes with renal oxidative metabolism: a potential pitfall in its use as an inhibitor of drug transport
Q44383564Probenecid-induced changes in the clearance of pranoprofen enantiomers
Q39140289Renal Drug Transporters and Drug Interactions
Q71485760Renal disposition and drug interaction screening of (-)-2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney
Q43224428Sodium valproate acutely inhibits lamotrigine metabolism
Q72361391The effect of probenecid on paracetamol metabolism and pharmacokinetics
Q53991051The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients.
Q34358547The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes
Q34345495The effects of indomethacin and naproxen on zidovudine pharmacokinetics
Q33933489Transport, metabolism and elimination mechanisms of anti-HIV agents
Q34403379Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide
Q39782074Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection
Q40491653Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy